Back to Publications
August, 2021

MORNINGSKY Trial

BlueClinical is involved, through its Clinical Research Partnership Network, on the Phase 3 MORNINGSKY trial

BlueClinical is involved, through its Clinical Research Partnership Network, on the Phase 3 MORNINGSKY trial, a global multicenter study evaluating AT-527 in mild or moderate COVID-19 patients in an outpatient setting.
 

Learn more at https://www.covid19morningsky.com/PT

Other Publication


Privacy and Data Protection Policy

Privacy and Data Protection Policy Update

CPhI 2019 Frankfurt

BlueClinical will be present in CPhI Worldwide 2019 in Frankfurt.